Laura L. Worth - Publications

Outcomes of children, adolescents, and young adults following allogeneic stem cell transplantation for secondary acute myeloid leukemia and myelodysplastic syndromes-The MD Anderson Cancer Center experience.

Journal: Pediatric transplantation

Published: December 27, 2016

Treatment of Severe Adult Traumatic Brain Injury Using Bone Marrow Mononuclear Cells.

Journal: Stem cells (Dayton, Ohio)

Published: August 01, 2016

Long-Term Outcomes after Treatment with Clofarabine ± Fludarabine with Once-Daily Intravenous Busulfan as Pretransplant Conditioning Therapy for Advanced Myeloid Leukemia and Myelodysplastic Syndrome.

Journal: Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation

Published: February 10, 2016

Autologous bone marrow mononuclear cells reduce therapeutic intensity for severe traumatic brain injury in children.

Journal: Pediatric critical care medicine : a journal of the Society of Critical Care Medicine and the World Federation of Pediatric Intensive and Critical Care Societies

Published: January 13, 2015

Exploring the Cancer Experiences of Young Adults in the Context of Stem Cell Transplantation.

Journal: Cancer nursing

Published: September 19, 2014

The development of a myeloablative, reduced-toxicity, conditioning regimen for cord blood transplantation.

Journal: Clinical lymphoma, myeloma & leukemia

Published: May 31, 2013

Cord-blood engraftment with ex vivo mesenchymal-cell coculture.

Journal: The New England journal of medicine

Published: December 14, 2012

Feasibility of allografting in patients with advanced acute lymphoblastic leukemia after salvage therapy with inotuzumab ozogamicin.

Journal: Clinical lymphoma, myeloma & leukemia

Published: August 14, 2012

High-dose infusional gemcitabine combined with busulfan and melphalan with autologous stem-cell transplantation in patients with refractory lymphoid malignancies.

Journal: Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation

Published: March 30, 2012

Fludarabine, melphalan, thiotepa and anti-thymocyte globulin conditioning for unrelated cord blood transplant.

Journal: Leukemia & lymphoma

Published: October 13, 2011